Lucile Blaise
CIK 1938112 · View on SEC EDGAR ↗
Insider
First SEC filing: July 15, 2022 · Latest: July 15, 2022
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 10 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
10 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2022 | RMD | S 10b5-1 | 169 | $225.18 | $38,055 | 7,335 Direct | -2.25% | Disposed | 2.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 16, 2022 | RMD | ResMed Common Stock Options | ResMed Common Stock (2,410) | $224.58 | Nov. 16, 2029 | 2,410 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 15, 2022 | RMD | ResMed Common Stock | 6,915 | Direct |